SEC Filing Summary: Ra Medical Systems, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on April 24, 2023. The registrant is a Delaware corporation with its principal executive offices in Fort Mill, SC, and its common stock trades on the NYSE American under the symbol RMED. The company is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of corporate governance events and does not contain financial performance data.
Material Changes
The primary material change disclosed is the scheduling of the 2023 Annual Meeting of Shareholders for July 11, 2023. Due to this date being more than 30 days after the previous year's meeting, the deadline for submitting shareholder proposals under Rule 14a-8 has been updated.
- New Proposal Deadline: May 9, 2023.
- Bylaw Proposals: Deadlines for proposals or director nominations under Section 2.4 of the Amended and Restated Bylaws remain unchanged from the 2022 proxy materials.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document serves solely to inform stockholders of the meeting date and the revised deadline for shareholder proposals.
Key Facts for Investor Verification
- Verify the Annual Meeting date of July 11, 2023, and the May 9, 2023, deadline for Rule 14a-8 shareholder proposals.
- Confirm that the company name is Ra Medical Systems, Inc. (RMED), as the input metadata referenced a different entity name.
- Note that proxy materials with detailed meeting information will be made available shortly after this filing.